相关实验视频

Updated: Jul 28, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

梅特福明通过自途径增强脂肪衍生干细胞的VEGFa分泌,促进血管生成

Zihan Tao¹, Lei Liu¹, Minliang Wu¹

¹Department of Plastic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.

Regenerative biomaterials

|May 30, 2023

概括

甲福明通过促进血管生成,加速伤口愈合,增强脂肪组织衍生干细胞 (ADSC) 衍生物. 这项研究发现,用MET治疗的ADSC显著改善了血管形成和治疗疗效.

科学领域:

再生医学是一种再生医学.
干细胞生物学干细胞生物学
生物化学生物化学

背景情况:

脂肪组织衍生干细胞 (ADSC) 衍生品为伤口愈合提供无细胞治疗潜力.
ADSC衍生品的质量变化阻碍了临床转化.
甲胺 (MET) 是一种已知的AMPK激活剂,它会影响细胞过程,如自.

研究的目的:

为了评估MET对ADSC衍生物对增强血管生成的影响.
阐明MET对ADSC介导伤口愈合的影响背后的机制.
评估MET治疗的ADSC在促进血管生成方面的治疗潜力.

主要方法:

在体外评估MET对ADSC增殖,血管生成能力和自的影响.
测量血管内皮生长因子A (VEGF-A) 的产生.
在体内评估MET治疗ADSC对伤口模型中的血管生成的影响.

主要成果:

低MET度没有影响ADSC增殖,但增强了血管生成能力和自性.
由MET诱导的自与增加的VEGF-A生产和释放相关.
在体内研究表明,与未经治疗的ADSC相比,MET治疗的ADSC显著促进了血管生成.

结论:

MET治疗增强了ADSC衍生物的血管新生潜力.
由MET诱导的自和随后的VEGF-A释放是推动治疗疗效的关键机制.
用MET治疗的ADSC代表了通过改善血管生成加速伤口愈合的有希望的策略.

关键词:

血管新生的产生.人类脂肪组织衍生的干细胞.甲胺是一种甲胺.干细胞是一种干细胞.伤口愈合伤口愈合

更多相关视频

Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue

Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue

Published on: February 13, 2019

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...